[Experimental rationale for the optimization of chemotherapy for alveococciasis].
作者信息
Chernikova E A, Legon'kov Iu A, Kovalenko F P
出版信息
Med Parazitol (Mosk). 2005 Jan-Mar(1):43-5.
PMID:15801219
Abstract
摘要
相似文献
1
[Experimental rationale for the optimization of chemotherapy for alveococciasis].
Med Parazitol (Mosk). 2005 Jan-Mar(1):43-5.
2
[Thoracic hydatid cysts: news].
Rev Mal Respir. 2006 Sep;23(4 Pt 2):10S80-10S82.
3
Morphobiology of Echinococcus granulosus and therapeutic trials in sheep.
J Chemother. 1989 Jul;1(4 Suppl):255-6.
4
Comparison of albendazole, mebendazole and praziquantel chemotherapy of Echinococcus multilocularis in a gerbil model.
Gut. 1989 Oct;30(10):1401-5. doi: 10.1136/gut.30.10.1401.
5
Benzimidazoles for the treatment of cystic and alveolar echinococcosis: what is the consensus?
Expert Rev Anti Infect Ther. 2009 Mar;7(2):145-9. doi: 10.1586/14787210.7.2.145.
6
7
[Chemotherapy in echinococcosis].
Enferm Infecc Microbiol Clin. 1991 Nov;9(9):523-6.
8
Treatment of echinococcosis: albendazole and mebendazole--what else?
Parasite. 2014;21:70. doi: 10.1051/parasite/2014073. Epub 2014 Dec 22.
9
Pulmonary hydatidosis medical and surgical management.
J Assoc Physicians India. 1996 Jan;44(1):63-4.
10
Editorial response: Treatment of cystic echinococcosis--improving but still limited.
Clin Infect Dis. 1999 Aug;29(2):310-1. doi: 10.1086/520206.
Zotero 插件